Tag: Liver Disease: Misc.
Uric Acid Concentration, Fructose Intake Up NASH in Children
Independent associations seen in cohort of obese children with non-alcoholic fatty liver disease
hCG Reduces Caspase-3-Dependent IL-16 Expression
Absence of Caspase-3 activity results in reduction of processing and release of interleukin-16
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD
Reduced all-cause death for chronic kidney disease, congestive heart failure, chronic liver disease
Addiction Consultation Valuable for Liver Transplant Patients
Increased alcohol consumption identified in interviews with addiction specialists vs hepatologists
Recommendations Developed for Pediatric NAFLD
Recommendations relate to screening, diagnosis, treatment, and long-term care of pediatric NAFLD
Bariatric Surgery Effective, Cost-Effective in Obese With NASH
For overweight patients, surgery is effective, but cost-effectiveness limited to those with F3 fibrosis
Optimal MELD Threshold for HCV Tx Pre-Liver Transplant 23 to 27
Treating HCV before liver transplant increased life expectancy if MELD was ≤27
Herbal, Dietary Supplements Cause One-Fifth of Hepatotoxicity
Major implicated agents include anabolic steroids, green tea, multi-ingredient nutritional supplements
Liver Stiffness Linked to Hepatic Events, Death in Hepatitis B
Metabolic syndrome ups risk of cardiovascular events, not hepatic events or death in chronic hep B
Burden of Cirrhosis, Acute-on-Chronic Liver Failure Increasing
From 2001 to 2011, number of hospitalizations for cirrhosis nearly doubled; prevalence of ACLF up
